Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


EEG device 510(k)s need clinical data for most diagnostic claims -- FDA draft guidance.

This article was originally published in The Gray Sheet

Executive Summary

EEG DEVICE 510(k)s NEED CLINICAL DATA FOR DIAGNOSTIC CLAIMS OTHER THAN EPILEPSY, FDA says in a draft guidance on 510(k)s for electroencephalograph devices. Noting that the only diagnostic EEG claim that has been cleared via 510(k) is "aiding the physician in diagnosing epilepsy," FDA says that "any other intended use, including diagnostic claims that the manufacturer makes about the device's capabilities, should be supported by clinical data." Comments on the guidance are due by Jan. 2.



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts